"The Effect of Lavender Aromatherapy on Dental Anxiety"
1 other identifier
interventional
68
0 countries
N/A
Brief Summary
ABSTRACT Background: Dental anxiety is addressed as a common issue in adults, often delaying necessary dental treatments and impacting overall oral health. Conventional anxiety management methods may not be preferred due to certain limitations, therefore prompting interest in complementary therapies. The most promising therapy is aromatherapy. Aromatherapy uses essential oils for relaxation to reduce stress. This approach is non-invasive and accessible, making it a promising option for reducing dental anxiety. This study will examine the effect of aromatherapy in adults undergoing dental treatment, highlighting holistic strategies in dental care. Aim of the study: This study aimed to determine the effect of aromatherapy on dental anxiety among dental patients. Methodology: The study will be a randomized control trial, with 68 participants divided into two groups, Experimental (aromatherapy) and Control, randomizing through Sequentially Numbered, Opaque, and Sealed Envelopes (SNOSE). This trial will be conducted at dental OPD, Dr. Ishrat ul Ebad Khan Institute of Oral Health Sciences. The patients of both gender aged 20-45 years, requiring any dental procedure and providing an informed consent form will be part of the study. Patients with colds, asthma, or other respiratory diseases, acoustic problems, allergic to lavender oils used in the study and mental and physical disabilities will be excluded. It will be a single-blinded study where the examiner is unaware of group allocation. Questionnaires will be used to evaluate patient anxiety levels before the intervention and after dental procedure. Intervention (Aromatherapy) will be administered via nebulizer for 15 minutes. The control group will receive placebo intervention via nebulizer filled with normal saline for 15 minutes. Physiological data will be collected to measure stress response, including systolic and diastolic blood pressure, pulse rate, and oxygen saturation, using a digital sphygmomanometer and pulse oximeter at the start of the intervention (baseline) and at the end of the dental procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 27, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
September 10, 2026
August 1, 2026
5 months
August 27, 2026
September 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Dental anxiety
Dental Anxiety status measured by Modified Dental anxiety scale. The minimum and maximum values recorded by Modified dental anxiety scale will be \< 10 and \>19 respectively and the higher scores means high dental anxiety which is worse outcome
one hour
Secondary Outcomes (3)
Physiological Parameters
One hour
Physiological Parameter
one hour
Physiological Parameter
one hour
Study Arms (2)
Experimental: Aromatherapy will be administered.
EXPERIMENTALLavender Aromatherapy will administrated to Experimental group
Group 2: (Control): Placebo intervention
PLACEBO COMPARATORInterventions
Lavender Aromatherapy will administrated to Experimental group
The control group will receive placebo intervention via nebulizer filled with normal saline for 15 minutes to remain calm and anxiety free.
Eligibility Criteria
You may qualify if:
- Patients who will give consent to the study.
- Patients aged 20-45 years undergoing dental treatment for the first time.
- Both gender.
- Patient seeking any one of the following dental procedures: root canal treatment, scaling and polishing or tooth extraction.
You may not qualify if:
- Patients with colds, asthma, and any other respiratory diseases.
- Patients with acoustic problems.
- Patients who are allergic Lavender oils that have been used in this study.
- Patients with mental and physical disabilities.
- Patient who may refuse to continue the intervention will be excluded.
- Non cooperative patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Karan NB. Influence of lavender oil inhalation on vital signs and anxiety: A randomized clinical trial. Physiol Behav. 2019 Nov 1;211:112676. doi: 10.1016/j.physbeh.2019.112676. Epub 2019 Sep 7.
PMID: 31505191RESULTKritsidima M, Newton T, Asimakopoulou K. The effects of lavender scent on dental patient anxiety levels: a cluster randomised-controlled trial. Community Dent Oral Epidemiol. 2010 Feb;38(1):83-7. doi: 10.1111/j.1600-0528.2009.00511.x. Epub 2009 Nov 23.
PMID: 19968674RESULT
Related Links
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Sadaf Arshi (dr.sadaf arshi)
Study Record Dates
First Submitted
August 27, 2026
First Posted
September 10, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
January 31, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
September 10, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be made publicly accessible. Access to the IPD and supporting study documents will be restricted to the Principal Investigator and authorized members of the research team. De-identified data may be made available to qualified researchers upon reasonable request, subject to approval by the Principal Investigator/Institutional Review Board and compliance with applicable confidentiality and data-protection requirements.